Renaissance Capital logo
IPO Center

Synta Pharmaceuticals

, Nasdaq: SNTA

A biotech developing drugs for chronic inflammatory diseases and cancer.

Industry: Health Care

First Day Return: -9.1%

A biotech developing drugs for chronic inflammatory diseases and cancer.
IPO Data
IPO Date 02/05/2007
Offer Price IPO Intelligence Only
Price Range IPO Intelligence Only
Offer Shares (mm) IPO Intelligence Only
Deal Size ($mm) $50
Lock-Up Date IPO Intelligence Only
Street Research IPO Intelligence Only
Underwriters
IPO Intelligence Only
Company Data
Headquarters Lexington, MA, United States
Founded 2001
Employees at IPO n/a
Website www.syntapharma.com

Synta Pharmaceuticals (SNTA) Performance

Follow Us

IPO ETFs

IPO Center

IPO Pro

IPO Intelligence

IPO Data

About Us

Important Disclosures
Renaissance Capital LLC is an SEC-registered investment adviser.
© 2026 Renaissance Capital LLC. All rights reserved.